Redhill Biopharma
RDHL
11 hedge funds and large institutions have $103K invested in Redhill Biopharma in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
112% more capital invested
Capital invested by funds: $48.8K → $103K (+$54.7K)
0% more funds holding
Funds holding: 11 → 11 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0.03% less ownership
Funds ownership: 0.03% → 0% (-0.03%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GI
GAMMA Investing
Foster City,
California
|
+$38.9K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$33.4K |
| 3 |
Morgan Stanley
New York
|
+$15.5K |
| 4 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$1.67K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$8 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$4.62K |
| 2 |
CPA
Capital Performance Advisors
Walnut Creek,
California
|
-$44 |
| 3 |
DB
Danske Bank
Copenhagen K,
Denmark
|
-$17 |
| 4 |
IA
IFP Advisors
Tampa,
Florida
|
-$2 |
RDHL Hedge Fund Activity: Q4 2024 in Review
11 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q4 2024, worth a combined $103K — up 112% from $48.8K a quarter earlier.
Fund positioning in RDHL was balanced in Q4 2024: 3 funds opened new positions, 3 closed out, 4 added to existing stakes and 1 trimmed.
The largest buyer was GAMMA Investing, opening a new position worth an estimated $38.9K. The largest seller was Federation des caisses Desjardins du Quebec, cutting an estimated $4.62K.
- 11 institutional investors held Redhill Biopharma (RDHL) as of Q4 2024, unchanged from Q3 2024.
- Funds reported $103K of Redhill Biopharma stock for Q4 2024, up 112% quarter-over-quarter.
- 3 funds opened new Redhill Biopharma positions in Q4 2024 and 3 closed out, a net change of 0 holders.
- The largest Redhill Biopharma buyer in Q4 2024 was GAMMA Investing, an estimated $38.9K added.
- The largest Redhill Biopharma seller in Q4 2024 was Federation des caisses Desjardins du Quebec, an estimated $4.62K sold.
Based on aggregated 13F filings for Q4 2024.